Furthermore, it was mechanistically revealed that RUNX3 controls the expression of genes responsible for the tissue-residency of CD8+ TRM cells as Runx3 downregulation severely promoted tumor growth [74]. The gene discussed is CD8A; the disease is neoplasm.